Cochlear Ltd
COH: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$891.00 | Svvb | Zwsdxbqyd |
Cochlear: ACCC Green Lights Oticon Acquisition
The Australian Competition & Consumer Commission has approved wide-moat Cochlear’s acquisition of Oticon’s cochlear implants business. We had expected this to proceed and maintain our AUD 220 fair value and earnings estimates.